Eagle Pharmaceuticals Inc. (NASDAQ: EGRX) Q3 2020 Earnings Call dated Nov. 02, 2020 Corporate Participants: Lisa M. Wilson -- Investor Relations - In-Site Communications,
Eagle Pharmaceuticals Inc.
-(EGRX)
XNAS:EGRX
Eagle Pharmaceuticals Inc (NASDAQ: EGRX) Q1 2020 Earnings Call Transcript
Eagle Pharmaceuticals Inc (EGRX) Q1 2020 earnings call dated May. 11, 2020 Corporate Participants: Lisa Wilson -- Investor Relations Scott Tarriff -- Founder, Chief Executive Officer
Eagle Pharmaceuticals (NASDAQ: EGRX): Q4 2019 Earnings Snapshot
-- Eagle Pharmaceuticals Inc. (NASDAQ: EGRX) reported its fourth-quarter 2019 adjusted earnings of $0.48 per share versus $0.46 per share expected. --